Related Experiment Videos
[Wilson disease: a new case treated with trientine]
J L Moreno Pérez-Crespo1, M L García de la Rocha, A Martín Araguz
1Servicio de Neurología, Hospital del Aire, Madrid.
Revista De Neurologia
|January 1, 1995
Summary
Wilson's disease (WD) is a rare genetic disorder affecting copper excretion. Early detection and alternative therapies to D-penicillamine are crucial for managing this condition.
Area of Science:
- Genetics
- Hepatology
- Neurology
Background:
- Hepatolenticular degeneration, or Wilson's disease (WD), is an infrequent autosomal recessive hereditary disorder.
- The genetic defect is located on chromosome 13 (13q14.3), leading to impaired copper (Cu) excretion.
- This results in anomalous copper deposition in various organs, causing neurological, hepatic, psychiatric, and ocular manifestations.
Observation:
- A case of a young patient presenting with depressive symptoms four years prior to diagnosis is detailed.
- The diagnostic delay highlights challenges in recognizing early Wilson's disease manifestations.
Findings:
- The study discusses the importance of early detection in asymptomatic patients with Wilson's disease.
- It also comments on the efficacy and safety of therapeutic options beyond D-penicillamine.
Implications:
- Prompt diagnosis of Wilson's disease is essential for initiating timely and effective treatment.
- Exploring alternative therapies may improve patient outcomes and reduce treatment-related side effects.